Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Driving Pressure and Postoperative Pulmonary Complications in Thoracic Surgery
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-02-07
- Last Posted Date
- 2021-07-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1300
- Registration Number
- NCT04260451
- Locations
- 🇰🇷
Samsung medical center, Seoul, Korea, Republic of
Effect of Intensive Nutritional Support in Subacute Stroke Patient
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 97
- Registration Number
- NCT04259307
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT04258072
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Ventilator-driven Alveolar Recruitment Maneuver
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2020-11-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 64
- Registration Number
- NCT04258202
- Locations
- 🇰🇷
Samsung medical center, Seoul, Korea, Republic of
Genetic Characteristics of Metastatic Breast Cancer Patients
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2020-02-06
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT04258735
- Locations
- 🇰🇷
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Liquid Biopsy Using Methylation Sequencing for Lung Cancer
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 280
- Registration Number
- NCT04253509
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive
- First Posted Date
- 2020-01-31
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 93
- Registration Number
- NCT04249739
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)
- First Posted Date
- 2020-01-30
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 578
- Registration Number
- NCT04247633
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
T-DM1 in HER2-positive Metastatic/Relapsed Breast Cancer
- Conditions
- First Posted Date
- 2019-12-17
- Last Posted Date
- 2019-12-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1000
- Registration Number
- NCT04202328
- Locations
- 🇰🇷
Hallym University Sacred Heart Hospital, Anyang, Korea, Republic of
🇰🇷Dong-A University Hospital, Busan, Korea, Republic of
🇰🇷Soonchunhyang University Cheonan Hospital, Cheonan, Korea, Republic of
Intravenous Iron Injection in Cancer Patients With Anemia
- First Posted Date
- 2019-12-05
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 341
- Registration Number
- NCT04187716
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath